MedAssets Receives New Coverage from Analysts at RBC Capital (MDAS)
Equities researchers at RBC Capital started coverage on shares of MedAssets (NASDAQ:MDAS) in a research report issued on Thursday, StockRatingsNetwork.com reports. The firm set a “sector perform” rating on the stock.
MedAssets (NASDAQ:MDAS) traded up 1.75% during mid-day trading on Thursday, hitting $21.47. 319,166 shares of the company’s stock traded hands. MedAssets has a 1-year low of $16.31 and a 1-year high of $26.58. The stock’s 50-day moving average is $20. and its 200-day moving average is $22.55. The company has a market cap of $1.328 billion and a P/E ratio of 251.19.
MDAS has been the subject of a number of other recent research reports. Analysts at Zacks upgraded shares of MedAssets from an “underperform” rating to a “neutral” rating in a research note on Monday, January 6th. They now have a $20.50 price target on the stock. Separately, analysts at JPMorgan Chase & Co. initiated coverage on shares of MedAssets in a research note on Monday, December 9th. They set a “neutral” rating and a $23.00 price target on the stock. Finally, analysts at KeyCorp upgraded shares of MedAssets from a “hold” rating to a “buy” rating in a research note on Monday, November 25th. They now have a $25.00 price target on the stock. Eight equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. MedAssets has a consensus rating of “Buy” and a consensus price target of $26.04.
MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.